VSBC Vitaspring Biomedical Co., Ltd.

Fundamentals / CIK 0001697884 / USD

Vitaspring Biomedical Co., Ltd. reported $0 in revenue and a net loss of $456K for the trailing twelve months ended July 31, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VSBC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$5.97M$2.99M$0-$4.37MFY 2017 Revenue: $0FY 2017 Net Income: -$452017FY 2018 Revenue: $16KFY 2018 Net Income: -$6.4K2018FY 2019 Revenue: $17KFY 2019 Net Income: -$22K2019FY 2020 Revenue: $15KFY 2020 Net Income: $6.9K2020FY 2021 Revenue: $248KFY 2021 Net Income: $425K2021FY 2022 Revenue: $5.61MFY 2022 Net Income: $910K2022FY 2023 Revenue: $0FY 2023 Net Income: -$4.16M2023FY 2024 Revenue: $0FY 2024 Net Income: -$1.12M2024FY 2025 Revenue: $0FY 2025 Net Income: -$775K2025FY 2026 Revenue: $0FY 2026 Net Income: -$415K2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31
Revenue $0 $0 $0 $0 $5.61M $248K $15K $17K $16K $0
Cost of Revenue $0 $0 $0 $3.33M $3.55M $136K $13K $3.5K $4.9K $0
Gross Profit $0 $0 $0 -$3.33M $2.07M $112K $1.7K $14K $11K $0
Selling, General & Admin $385K $680K $1.12M $845K $941K $538K $21K $36K -- --
Total Operating Expenses -- -- -- -- -- -- -- -$36K -$18K -$45
Operating Income -$385K -$680K -$1.12M -$4.18M $1.13M $425K $6.9K -$22K -$6.4K $45
EBITDA -$375K -$670K -$1.10M -$4.16M $1.14M $425K $7.4K -$22K -$6.0K $45
Income Before Tax -$385K -$680K -$1.12M -$4.17M $1.13M -$425K $6.9K -$22K -- --
Income Tax Expense $30K $95K $0 -$5.4K $217K $0 $0 $0 -- --
Net Income -$415K -$775K -$1.12M -$4.16M $910K $425K $6.9K -$22K -$6.4K -$45
Basic EPS -- -- -- -- -- $0.00 $0.00 $0.00 $0.00 $0.00
Diluted EPS $0.00 $0.00 -$0.01 -$0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Basic Shares Outstanding -- -- -- -- 206.0M 91.1M -- -- -- --
Diluted Shares Outstanding 207.0M 207.0M 207.0M 206.5M 206.0M 91.1M 10.9M 9.8M 2.3M 49.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Selling, General & Admin $5.8K $76K $81K $136K $6.1K $69K $126K $118K
Total Operating Expenses $162K -- -- -- $99K -- -- --
Operating Income -$162K -$76K -$81K -$136K -$99K -$69K -$126K -$118K
EBITDA -- -$73K -$79K -$133K -$97K -$67K -$124K -$115K
Income Before Tax -$156K -$76K -$81K -$136K -$99K -$69K -$126K -$118K
Income Tax Expense $0 $0 $0 $6.8K $12K $11K $17K $78K
Net Income -$156K -$76K -$81K -$143K -$111K -$81K -$143K -$196K
Diluted EPS $0.00 $0.00 -- $0.00 $0.00 $0.00 -- $0.00
Diluted Shares Outstanding 207.0M 207.0M -- 207.0M 207.0M 207.0M -- 207.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31
Cash & Cash Equivalents -- $0 $0 -- $107K $45K $0 $105 $5.2K $555
Cash & Short-Term Investments -- $0 $0 -- $107K $0 $0 $105 $5.2K $555
Accounts Receivable, Net -- $0 $0 $380K $2.95M -- -- -- -- --
Inventory -- -- -- $0 $0 $144K -- -- -- --
Other Current Assets -- -- -- -- -- -- -- $8.5K -- --
Total Current Assets $11K $272 $24K $437K $3.06M $189K $189K $10K $11K $4.6K
Property, Plant & Equipment, Net $4.1K $14K $24K $50K $65K -- -- $1.4K $1.9K $0
Total Non-Current Assets $4.1K $14K $114K $329K $542K $0 $0 $11K $13K $4.6K
Total Assets $15K $14K $137K $766K $3.60M $189K $189K $0 $1.9K $0
Accounts Payable $2.41M $2.41M $2.41M $2.41M $1.25M -- -- $0 $1.4K $0
Other Current Liabilities $652K $495K $339K $55K $0 $93K $93K -- -- --
Total Current Liabilities $4.45M $4.03M $3.49M $3.07M $1.74M $93K $93K $18K $16K $1.6K
Total Non-Current Liabilities $0 $0 $0 $93K $289K $0 $0 $18K $16K $1.6K
Total Liabilities $4.45M $4.03M $3.49M $3.16M $2.03M $93K $96K $11K $13K $4.6K
Total Debt (incl. Leases) -- -- $93K $93K $479K -- -- -- -- --
Common Stock $21K $21K $21K $21K $21K $19K $10.90M $0 $0 --
Retained Earnings -$5.70M -$5.28M -$4.51M -$3.39M $776K $447K -$447K -$29K -- --
Total Stockholders' Equity -$4.43M -$4.02M -$3.35M -$2.40M $1.58M $96K $0 -$6.9K -$3.4K $3.0K
Total Equity -$4.43M -$4.02M -$3.35M -$2.40M $1.58M $96K $0 -$6.9K -$3.4K $3.0K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents -- -- -- $0 $0 $0 $0 $2.1K
Cash & Short-Term Investments -- -- -- $0 $0 $0 $0 $2.1K
Accounts Receivable, Net -- -- -- -- -- -- $0 $0
Total Current Assets $15K $9.8K $11K $9.8K $7.9K $295 $272 $42K
Property, Plant & Equipment, Net $0 $1.7K $4.1K $6.6K $9.1K $12K $14K $17K
Total Non-Current Assets $0 $1.7K $4.1K $6.6K $9.1K $12K $14K $17K
Total Assets $15K $11K $15K $16K $17K $12K $14K $58K
Accounts Payable $0 -- $2.41M $2.41M $2.41M $2.41M $2.41M $2.41M
Other Current Liabilities -- $712K $652K -- -- $530K $495K $446K
Total Current Liabilities $2.27M $4.52M $4.45M $4.37M $4.22M $4.11M $4.03M $3.93M
Total Non-Current Liabilities $2.41M $0 $0 $0 $0 $0 $0 $0
Total Liabilities $4.68M $4.52M $4.45M $4.37M $4.22M $4.11M $4.03M $3.93M
Common Stock $21K $21K $21K $21K $21K $21K $21K $21K
Retained Earnings -$5.93M -$5.77M -$5.70M -$5.62M -$5.47M -$5.36M -$5.28M -$5.14M
Total Stockholders' Equity -$4.66M -$4.51M -$4.43M -$4.35M -$4.21M -$4.10M -$4.02M -$3.87M
Total Equity -$4.66M -$4.51M -$4.43M -$4.35M -$4.21M -$4.10M -$4.02M -$3.87M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31
Net Income -$415K -$775K -$1.12M -$4.16M $910K $425K $6.9K -$22K -$6.4K -$45
Depreciation & Amortization $10.0K $10.0K $15K $15K $8.4K $0 $450 $450 $375 $0
Stock-Based Compensation $0 $110K $165K $190K $167K $434K -- -- -- --
Change in Receivables -- $0 $380K $2.54M -$2.95M -- -- -- -- --
Change in Inventory -- -- -- $0 $144K -$144K -- -- -- --
Change in Payables -- -- -- -- -- -- -- -$1.4K $1.4K $0
Operating Cash Flow -$2.7K -$15K -$35K -$78K -$270K -$42K $105 -$34K $401 -$4.0K
Capital Expenditure -- -- -- $0 -$73K -- -- -- -- --
Free Cash Flow -- -- -- -$78K -$343K -- -- -- -- --
Investing Cash Flow -- -- -- $0 -$73K -- -- $0 -$2.2K $0
Common Stock Issued -- -- -- $0 $50K $8.7K $0 $19K $0 $3.0K
Share Repurchases -- -- -- -- -- -- -- -- -$100 --
Financing Cash Flow $4.5K $15K $5.3K $0 $50K $88K $0 $29K $6.5K $4.6K
Net Change in Cash $1.8K $259 -$30K -$78K -$293K $45K -$105 -$5.1K -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$156K -$76K -$81K -$143K -$111K -$81K -$143K -$196K
Depreciation & Amortization -- $2.5K $2.5K $2.5K $2.5K $2.5K $2.5K $2.5K
Stock-Based Compensation -- -- $0 $0 $0 $0 $0 $27K
Change in Receivables -- -- -- -- -- -- $0 $0
Operating Cash Flow $5.2K $6.1K $124 -$839 -$1.2K -$787 -$1.8K -$6.4K
Financing Cash Flow $0 $0 $0 $2.0K $2.0K $515 $0 $3.0K
Net Change in Cash $5.2K $6.1K $124 $1.2K $799 -$272 -$1.8K -$3.5K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31 Jan 31
Gross Margin -- -- -- -- 36.8% 45.2% 11.2% 79.8% 69.9% --
Operating Margin -- -- -- -- 20.1% 171.4% 45.7% -130.4% -39.3% --
Net Profit Margin -- -- -- -- 16.2% 171.4% 45.7% -130.4% -39.3% --
Return on Equity (ROE) -- -- -- -- 57.7% 441.4% -- -- -- -1.5%
Return on Assets (ROA) -2830.3% -5389.6% -814.4% -543.7% 25.2% 224.6% 3.7% -- -340.1% --
Current Ratio 0.00x 0.00x 0.01x 0.14x 1.76x 2.04x 2.04x 0.55x 0.68x 2.85x
Quick Ratio -- 0.00x 0.00x 0.14x 1.76x 0.49x 0.00x 0.01x 0.32x 0.35x
Debt to Equity -- -- -- -- 0.30x -- -- -- -- --
Revenue Growth (YoY) -- -- -- -100.0% +2161.6% +1539.4% -11.9% +5.9% -- --
Gross Profit Growth (YoY) -- -- -- -261.2% +1743.1% +6519.5% -87.6% +21.0% -- --
Operating Income Growth (YoY) -- -- -- -470.8% +164.9% +6048.0% -- -- -14264.4% --
Net Income Growth (YoY) -- -- -- -557.8% +113.8% +6048.0% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -40223.8% -- -8640.6% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Return on Assets (ROA) -3074.1% -3592.3% -2830.3% -2897.3% -3118.8% -5361.2% -5389.6% -1468.2%
Current Ratio 0.01x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x
Quick Ratio -- -- -- 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001697884) · from January 31, 2017 Data through July 31, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal